Image
DEEP DIVE ANALYSIS • NSE: NEWGEN • FY26 RESULTS Newgen Software Technologies Ltd: From ₹1,336 TO ₹493 — Valuation Reset or the Next Enterprise AI Compounder?  What the Q4 FY26 Numbers Actually Reveal Beneath the Midcap IT Bloodbath By SUMAN MUKHOPADHYAY | SumanSpeaks Independent Research • June 02, 2026 Newgen Software Technologies Ltd (Rs. 493)   was last trading at a pproximately ₹493 — down nearly 63% from its 52-week high near ₹1,336. In most cases, such a collapse signals severe business deterioration. But Newgen’s FY26 financials tell a far more complicated story. The company remains debt-light, highly profitable, cash-generative, and structurally positioned in one of the most important enterprise themes globally: AI-enabled workflow orchestration. Yet the stock has suffered one of the sharpest valuation compressions in the Indian en...
Insecticides India granted process patent for Acetamiprid
[Editor: Buy Insecticides (India) Ltd (BSE Code: 532851) at CMP of Rs.280-282, for an immediate target of Rs.320. Both the DIIs and FIIs have increased their stake in the company in Q3FY14 as against Q2FY14]
New Delhi  April 19, 2014: Indian Patent Office has granted Insecticides India Ltd (IIL) a process patent for an insecticide product – giving a shot in the arm for the research and development efforts of the company. The patent has been granted for process of preparing Acetamiprid, an insecticide for sucking pests. IIL, which has also partnered with Japan’s OAT Agrio Co Ltd to set up a joint venture for invention of new molecules in India for the international requirements, has so far filed for eight patents for process of different chemical compounds.

“This was the efforts from the in-house research and development centre. We had filed for the patent with India's Controller General of Patents, Designs & Trademarks for process of preparation for Acetamiprid technical in 2005. Though the process took a longer time, still we are optimistic for our other applications as well. This grant will encourage our team to work further in this direction,” said Rajesh Aggarwal, Managing Director, Insecticides India.  

Dr Mukesh, General Manager, R&D and Quality Control, Insecticides India, added, “At IIL, we put a lot of focus on research and development. Our R&D centre at Chopanki in Rajasthan is a testimony to this. The grant for process of preparing Acetamiprid will boost our efforts for further research. We are excited about this achievement and look forward.”

Insecticides India is one of the leading agrochemicals manufacturing company with a top line of Rs 650 crore in last fiscal (2012-13). The company is expected to touch Rs 900 crore this fiscal.

Comments

Popular posts from this blog